0001415889-24-008643.txt : 20240319
0001415889-24-008643.hdr.sgml : 20240319
20240319190744
ACCESSION NUMBER: 0001415889-24-008643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240318
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooper Simon Peter
CENTRAL INDEX KEY: 0001877225
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 24765694
MAIL ADDRESS:
STREET 1: C/O KEROS THERAPEUTICS, INC.
STREET 2: 99 HAYDEN AVE., BUILDING E, SUITE 120
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 996-0955
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
form4-03192024_110335.xml
X0508
4
2024-03-18
0001679363
Morphic Holding, Inc.
MORF
0001877225
Cooper Simon Peter
C/O MORPHIC HOLDING, INC.
35 GATEHOUSE DRIVE A2
WALTHAM
MA
02451
false
true
false
false
CMO
0
Employee Stock Options (right to buy)
33.46
2024-03-18
4
A
0
170000
0
A
Common Stock
170000
170000
D
Restricted Stock Unit
2024-03-18
4
A
0
14000
0
A
Common Stock
14000
14000
D
Restricted Stock Unit
2024-03-18
4
A
0
7000
0
A
Common Stock
7000
7000
D
The option vests as to 25% of the total shares on March 18, 2025, and then 2.0833% of the remaining shares shall vest monthly thereafter, subject to the reporting person's provision of service to the issuer on each vesting date.
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
The RSUs vest as to 25% of the total shares on each of March 18, 2025, March 18, 2026, March 18, 2027 and March 18, 2028, subject to the reporting person's provision of service to the issuer on each vesting date.
The RSUs vest as to 50% of the total shares on March 18, 2025 and 50% of the total shares on September 18, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Robert Farrell, as attorney-in-fact for Simon Cooper
2024-03-19